Showing 145,341 - 145,360 results of 224,673 for search '(( 5 ((step decrease) OR (nn decrease)) ) OR ( 10 ((teer decrease) OR (a decrease)) ))', query time: 2.15s Refine Results
  1. 145341

    Cophylogenetic signal occurs between hominids and fungal OTUs clustered at 99% similarity. by Emily P. Van Syoc (22169869)

    Published 2025
    “…The data underlying this figure can be found at <a href="https://doi.org/10.5281/zenodo.16749612" target="_blank">https://doi.org/10.5281/zenodo.16749612</a>.…”
  2. 145342

    Comparison of multiparametric datasets for neighboring genes within lipid-trait-associated loci. by Peter Blattmann (170585)

    Published 2013
    “…Phenotypes (red, increasing; blue, decreasing) meeting statistical criteria as described in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003338#s3" target="_blank">Materials and Methods</a> are framed in orange.…”
  3. 145343

    Correlation between residue 30 and other residues in calmodulin. by Kateri H. DuBay (343005)

    Published 2013
    “…Here, red represents increased entropy and blue decreased entropy (see right scale bar). See <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002168#s4" target="_blank">Methods</a> for details.…”
  4. 145344

    List of proteins belonging to cell envelope stress response pathways whose level changes upon LptC depletion. by Alessandra M. Martorana (589438)

    Published 2014
    “…<p>A. Relative abundance is calculated as the ratio beetween FL905 grown under permissive and non permissive conditions: ↑, increased; ↓, decreased (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100941#pone-0100941-t001" target="_blank">Tables 1</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100941#pone-0100941-t002" target="_blank">2</a>. 4). …”
  5. 145345

    Sub-division of psoriasis lesions into IL-13-strong and IL-13-weak groups based on genome-wide expression profiles. by William R. Swindell (175427)

    Published 2012
    “…For each set (columns) and subject (rows), chart colors denote the ratio of PP-increased to PP-decreased transcripts (see scale and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0034594#s4" target="_blank">Methods</a>). …”
  6. 145346

    Simulation results for PTSD healthcare costs in 2025 for the military, the VA, and the total military-VA system under the three scenarios and interventions (Policy 1–7). by Navid Ghaffarzadegan (733507)

    Published 2016
    “…—One way to read the figures is to compare the effects of policies in a scenario (e.g., scenario 1). In <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0161405#pone.0161405.g004" target="_blank">Fig 4</a>, e.g., in the military under scenario 1 (little involvement in future wars), PTSD prevalence was estimated to be 6.7% in the base run. …”
  7. 145347

    Invasibility of autoregulatory binding sites. by Alexander J. Stewart (392679)

    Published 2013
    “…Weak binding occurs when <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002992#pcbi.1002992-Becskei1" target="_blank">[1]</a>, <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002992#pcbi.1002992-Rosenfeld1" target="_blank">[2]</a>. …”
  8. 145348

    Axonal outgrowth in the injured spinal cord after high-dose ChABC treatment. by Chu-Hsun Cheng (798713)

    Published 2015
    “…<p>Longitudinal spinal cord sections from the control (A, D) and the 50 U (B, E) and 100 U (C, F) ChABC-treated groups were labeled with β-III tubulin (red) and GFAP (green, astrocytes) at 4 (A-C) and 10 (D-F) weeks after spinal cord injury; the dotted square indicates the higher magnification image of the lesion epicenter in each group (A’-F’). …”
  9. 145349

    Model simulations showing Ca<sup>2+</sup> and IP<sub>3</sub> responses to inhibition of Ca<sup>2+</sup> feedback on PLC. by Jung Min Han (195593)

    Published 2017
    “…However, numerical computations indicate that when <i>ψ</i><sub>2</sub> is decreased from 0.8 <i>μ</i>M s<sup>–1</sup> to 0 <i>μ</i>M s<sup>–1</sup>, the increase in the frequency is about 24%; see <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1005275#pcbi.1005275.t004" target="_blank">Table 4</a>. …”
  10. 145350

    Variation of macroscale measurables with the activator production rate by Philip J. Murray (108828)

    Published 2012
    “…The shallower potential well for the mutant parameters (dot-dashed line) explains why decreases with increasing . (d) The wave velocity, , (calculated using a numerical solution of <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002804#pcbi.1002804.e126" target="_blank">equations (12)</a> and <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002804#pcbi.1002804.e127" target="_blank">(13)</a>) is plotted against . …”
  11. 145351

    Micrographs of pancreatic tissues of different groups of rabbits. by Binish Arif (11909837)

    Published 2022
    “…Haematoxylin & Eosin x 10X. (<b>D</b>) Aminoguanidine treated diabetic rabbits showing near normal appearance of islet with a central core of beta cells (I). …”
  12. 145352

    Metabolic syndrome network visualizing cardiovascular risk factor burden, clustering, and flow of its components between baseline and five-year follow-up. by Robin Haring (149871)

    Published 2013
    “…<p>“<b>Healthy</b>”, no prevalent metabolic syndrome component; “<b>Obesity</b>”, waist circumference: men <u>></u>94 cm, women <u>></u> 80 cm; “<b>Glucose</b>”, elevated non-fasting glucose: ≥8.0 mmol/l or antidiabetic treatment (anatomic-therapeutical-chemical [ATC] codes A10A, A10B); “<b>HDL</b>”, decreased high-density lipoprotein cholesterol: men <1.0 mmol/l, women <1.3 mmol/l, or lipid-lowering treatment (ATC C10AB, A10AD); “<b>TG</b>”, elevated non-fasting triglycerides: ≥2.3 mmol/l or lipid-lowering treatment (ATC C10AB, A10AD); “<b>BP</b>”, elevated blood pressure: ≥130/85 mmHg or antihypertensive drug treatment. …”
  13. 145353

    Celecoxib regulates DAF-16 target gene expression. by Shanqing Zheng (580460)

    Published 2014
    “…<p><i>scl-20, K09F6.6, ins-7</i>, and <i>sod-3</i> expression profiles in <i>daf-2 (e1370) III</i> mutants compared to N2 worms (<b>A</b>). <i>ins-7</i> was significantly upregulated in N2 worms treated with 10 µM celecoxib (<b>B</b>). …”
  14. 145354

    Celecoxib regulates DAF-16 target gene expression. by Shanqing Zheng (580460)

    Published 2014
    “…<p><i>scl-20, K09F6.6, ins-7</i>, and <i>sod-3</i> expression profiles in <i>daf-2 (e1370) III</i> mutants compared to N2 worms (<b>A</b>). <i>ins-7</i> was significantly upregulated in N2 worms treated with 10 µM celecoxib (<b>B</b>). …”
  15. 145355

    Supplementary Material for: Prognostic Accuracy of Mild Cognitive Impairment Subtypes at Different Cut-Off Levels by Göthlin M. (4092352)

    Published 2017
    “…For aMCI-md, sensitivity increased and specificity decreased when the cut-off was lowered from 2.0 to 1.5 and 1.0 SD. …”
  16. 145356

    Growth of T7 phage Δ4107 by Joe GG Vethanayagam (6252)

    Published 2011
    “…Host strain was BL21(λDE3) freshly transformed with pJW25. 0.1 ml of phage from a 10dilution was plated. C. Host strain was BL21(λDE3) carrying pJW25 after 10 subculturings. 0.1 ml of phage from a 10dilution was plated.…”
  17. 145357

    The effects of anatomical parameters on detection distances of three targets against downwelling radiance modelled across depths. by Zahra M. Bagheri (13970425)

    Published 2022
    “…<p>Rows show the effects of increasing or decreasing the test parameter by a factor of two on the maximum detection distance. …”
  18. 145358

    Tetramisole reduces both worm speed and thrashing. by Timothy Kassis (664099)

    Published 2014
    “…The gray interval represents a 10-minute gap when the drug was added and imaging session restarted. …”
  19. 145359

    Model predictions of the effect of ligand depletion (left) show close agreement to experimental data (right). by Joanne L. Dunster (828678)

    Published 2015
    “…<p>Model profiles of Syk activity are the result of a series of simulations where the ligand is decreased from 100% through to 1% of its original value. …”
  20. 145360

    The risk of contracting VL. by Cameron Davis (19803404)

    Published 2024
    “…<p>The risk of contracting VL, is a decreasing function of the ITN population coverage . …”